Summary
The kinetics of marrow engraftment were analyzed in 50 patient with acute leukemia (21), malignant lymphoma (15), and solid tumors (14) after high-dose multiagent chemotherapy followed by autologous bone marrow transplantation (ABMT) with nonfrozen bone marrow. Unseparated heparinized whole bone marrow was stored in 10% CPDA1 at 4°C for 72 h, then filtered and reinfused. The median number of nucleated cells reinfused was 1.6×108/kg (range 0.5–3.8×108/kg). All patients had a full hematopoietic reconstitution. Median time to achieve a neutrophil count > 500/μl was 20 days (range 12–39) and median time to achieve an unsupported platelet count > 20.000/μl was 20 days (range 10–55). The main factor associated with delayed engraftment was the number of prior chemotherapy cycles. We conclude that high-dose chemotherapy with nonfrozen ABMT is a safe procedure, without the requirement for costly cryopreservation facilities.
Similar content being viewed by others
References
Beelen DW, Quabeck K, Graeven V, Sayer HG, Mahmoud HK, Schaefer VW (1989) Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclosphosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia. Blood 74: 1507–1516
Brandwein IM, Callum I, Sutcliffe SB, Scott IG, Keating A (1990) Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma. Bone Marrow Transplant 6: 291–294
Buckner CD, Appelbaum FR, Thomas ED (1981) Bone marrow and fetal liver. In: Karow AM Jr, Pegg DE (eds) Organ preservation for transplantation. Dekker, New York, pp 355–375
Burnett AK, Tansey P, Hills C, Alcorn MJ, Shechan T, McDonald GA, Banham SW (1982) Haematological reconstitution following high-dose and supralethal chemo-radiotherapy using stored non-cryopreserved autologous bone marrow. Br J Haematol 54: 309–316
Carella AM, Santini G, Santoro A, Coser P, Frassoni F, Martinengo M, Nari S, Congin A, Giordano D, Cerri R, Damasio E, Lercari G, Occhini D, Marmont AM (1985) Massive chemotherapy with non-frozen autologous bone marrow transplantation in 13 cases of refractory Hodgkin's disease. Eur J Cancer Clin Oncol 21: 607–613
Carey PJ, Proctor SJ, Taylor P, Hamilton PJ, on behalf of members of the Northern Regional Bone Marrow Transplant Group: Abela M, Cartner JC, Chandler JC, Condie P, Evans RGB, Finney R, Galloway MJ, Goff D, Hargrave S, Hendrick A, Jackson GH, Kay L, Kesteven P, Lennard A, Lloyd H, Lucraft H, Maharaj D, O'Brien H, Qureshi M, Reid MM, Saunders P, Summerfield G, Tinegate H, West N, Youart A (1991) Autologous bone marrow transplantation for high-grade lymphoid malignancy using melphalan/irradiation conditioning without marrow purging or cryopreservation. Blood 77: 1593–1598
Colombat P, Gorin NC, Lemonnier MP, Binet C, Laporte IP, Douay L, Desbois I, Lopez M, Lamagreve IP, Najman A (1990) The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas. J Clin Oncol 8: 630–637
Cornblut MA, Corringham RET, Prentice HG, Boesen EM, McElwain TJ (1981) Treatment of Swing's sarcoma with highdose melphalan and autologous bone marrow transplantation. Cancer Treat Rep 65: 241–244
Douay L, Gorin NC, Mary IY, Lemarie E, Lopez M, Najman A, Stachowiak I, Giarratana MC, Baillou C, Salmon F (1986) Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp Hematol 14: 358–365
Dunphy FR, Spitzer G, Buzdar AU, Hortobagyi GN, Horwitz LJ, Yau IC, Spinolo AJ, Jagannath S, Holmes F, Walterstein RO, Bohannan PA, Dicke KA (1990) Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support. J Clin Oncol 8: 1207–1216
Freedman AS, Takvorian T, Anderson KC, Mauch P, Rabinowe SN, Blake K, Yeap B, Soiffer R, Coral F, Heflin L, Ritz J, Nadler LM (1990) Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. J Clin Oncol 8: 784–791
Gribben JG, Linch DC, Singer CRJ, Mc Millan AK, Jarret M, Goldstone AH (1989) Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation. Blood 73: 340–344
Hill RS, Mazza P, Amos D, Buckner CD, Appelbaum FR, Martin P, Still BJ, Sica S, Berenson R, Bensinger W, Clift RA, Stewart P, Doney K, Sanders J, Singer J, Sullivan KM, Witherspoon RP, Storb R, Livingston R, Chard R, Thomas ED (1989) Engraftment in 86 patients with lymphoid malignancy after autologous marrow transplantation. Bone Marrow Transplant 4: 69–74
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481
Köppler H, Pflüger KH, Wolf M, Weide R, Havemann K (1990) High-dose chemotherapy with noncryopreserved bone marrow transplantation for acute myeloid leukemia in first complete remission. Haematol Blood Transfusion 33: 699–701
Lasky LC, Mc Cullough J, Zanjani ED (1986) Liquid storage of unseparated human bone marrow. Transfusion 26: 331–334
Löwenberg B, Verdonck LJ, Dekker AW, Willemze R, Zwaan FE, de Planque M, Abels J, Sonneveld P, van der Lelie J, Goudsmit R, van Putten WLJ, Sizoo W, Hagenbeek A, de Gast GC (1990) Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study. J Clin Oncol 8: 287–294
Mangalik A, Robinson WA, Drebing C, Hartmann D, Joshi JH (1979) Liquid storage of bone marrow. Exp Hematol 7 [Suppl 5]: 76–94
Pritchard I, Mc Elwain TI, Graham-Pole J (1982) High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer 45: 86–94
Robinson WA, Hartmann DW, Mangalik A, Morton N, Joshi JH (1981) Autologous nonfrozen bone marrow transplantation after intensive chemotherapy: a pilot study. Acta Haematol 66: 145–153
Spitzer G, Verma DS, Fisher R, Zander A, Vellekoop L, Litam J, Mc Credie KB, Dicke KA (1980) The myeloid progenitor cell — its value in predicting hematopoietic recovery after autologous bone marrow transplantation. Blood 55: 317–323
Thomas ED, Storb R (1970) Technique for human marrow grafting. Blood 36: 507–515
Thomas MR, Robinson WA, Glode LM, Dantas MD, Koeppler H, Morton N, Sutherland J (1982) Treatment of advanced malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation. Am J Clin Oncol 5: 611–621
Visani G, Dinota A, Verlicchi F, Bandini G, Ricci P, Motta MR, Rizzi S, Lemoli RM, Poluzzi C, Gherlinzoni F (1988) Autologous bone marrow transplantation with non-Hodgkin's lymphoma: comparison of different parameters in predicting the kinetics of haematological recovery. Bone Marrow Transplant 3: 599–605
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Köppler, H., Pflüger, K.H. & Havemann, K. Hematopoietic reconstitution after high-dose chemotherapy and autologous nonfrozen bone marrow rescue. Ann Hematol 63, 253–258 (1991). https://doi.org/10.1007/BF01698374
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01698374